Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 7 de 7
Filtrer
1.
Minerva Pediatr ; 56(1): 83-90, 2004 Feb.
Article de Italien | MEDLINE | ID: mdl-15249917

RÉSUMÉ

AIM: Disordered eating behaviours can lead to clinically evident and serious eating disorders (ED). Aim of this paper is to determine their extent among adolescents and to evaluate the associated characteristics. METHODS: All students of a high school (age 14-18) have been asked to fill up the Eating Attitudes Test (EAT-26) anonymously. EAT-26 is a self-reported questionnaire identifying subjects at risk for ED. This questionnaire included also an integrative section, aimed at investigating some ED-related variables (family composition, diet among relatives, social relationships, spare time activities, self-esteem). Collected data have been analyzed using EpiInfo6. RESULTS: The study involved all the 902 students of the school; 833 questionnaires have been distributed and 701 were collected (89.4% from girls, 10.3% from boys). The percentage of EAT-26 positive boys (i.e. scoring = or > 20) is 3%, while for girls is 13.7%. A positive test significantly correlates with low self-esteem (OR = 46.67, CI = 13.16-182.04), contentious relationships with the mother (OR = 2.20, CI = 1.12-4.29) and the father (OR=2.45, CI=1.24-4.80). No significant correlation has been found for being an only child, living in a single-parent family having limited/not having social relationships, having unsatisfactory social relationships, spending spare time mostly alone, watching TV more than 2 h per day. CONCLUSION: Our data suggest an increasing diffusion in the risk for ED among adolescents. Personal characteristics and behaviours related to this risk are good start points to program projects focusing on primary and secondary prevention of ED in high schools.


Sujet(s)
Attitude , Comportement alimentaire , Troubles de l'alimentation/épidémiologie , Étudiants/statistiques et données numériques , Adolescent , Femelle , Humains , Mâle , Appréciation des risques , Facteurs de risque , Établissements scolaires , Enquêtes et questionnaires
2.
Minerva Pediatr ; 54(2): 139-45, 2002 Apr.
Article de Italien | MEDLINE | ID: mdl-11981528

RÉSUMÉ

BACKGROUND: Clinical evidence and epidemiological research show an increasing number of subjects trying to become lean and reaching consequently harmful weight conditions. Aim of this paper is to assess the risk for eating disorders during adolescence. METHODS: In a multicentric study high school students of 5 different districts of Northern Italy have been asked to fill up anonymously the Italian version of the American YRBSS (Youth Risk Behaviour Surveillance System) questionnaire. For each school a section has been selected and between January and March 1999, students of every level have been involved. The data enrollected have been analysed using EpiInfo6. RESULTS: The study involved 4135 adolescents (57% girls and 43% boys) coming from 260 classes and 47 different schools. The proportion of boys perceiving themselves as overweight and underweight was the same (22%), while the proportion of girls considering themselves overweight raised up to 42%. The majority of the girls (53%) is trying to slim making use of physical activity (48%), diets (32%), vomiting (8%) and drugs (5%). CONCLUSIONS: Our data suggest that specific projects focusing on primary and secondary prevention of eating disorders should be considered for high schools. In addition, further studies are suggested to understand characteristics and behaviours related to eating disorders.


Sujet(s)
Troubles de l'alimentation/épidémiologie , Troubles de l'alimentation/étiologie , Adolescent , Études de cohortes , Troubles de l'alimentation/prévention et contrôle , Femelle , Humains , Italie/épidémiologie , Mâle , Appréciation des risques , Facteurs de risque , Enquêtes et questionnaires
3.
Antivir Ther ; 5(1): 7-14, 2000 Mar.
Article de Anglais | MEDLINE | ID: mdl-10846586

RÉSUMÉ

We retrospectively studied 38 Italian recently HIV-1-infected subjects who seroconverted from 1994 to 1997 to investigate: (i) the prevalence of nucleoside reverse transcriptase inhibitors (NRTI)-related mutations at primary infection; (ii) the proportion of naturally occurring mutations in reverse transcriptase (RT) and protease regions of patients naive for non-nucleoside RT inhibitors (NNRTIs) and protease inhibitors (PIs); (iii) the drug-susceptibility to NRTIs and PIs in subjects with NRTI- and/or PI-related mutations; and (iv) the outcome of seroconverters treated with various NRTIs or NRTI/PI regimens. Baseline HIV-1 plasma viraemia and absolute CD4 count at baseline could not be used to distinguish patients with NRTI- and/or PI-related pre-existing mutations from those with wild-type virus (P = 0.693 and P = 0.542, respectively). The frequency of zidovudine-related mutations was 21% in the study period. The response to treatment was not significantly different in subjects with or without genotypic zidovudine-related mutations at primary infection (P = 0.744 for HIV-1 RNA and P = 0.102 for CD4 cells). Some natural variation (2.6%) was present within regions 98-108 and 179-190 of RT involved in NNRTI resistance. The high natural polymorphism in the protease region present in our patients was similar to that reported by others. In our study some PI-associated substitutions, thought to be compensatory in protease enzymatic function, could confer intermediate to high PI-resistance. As discrepancies between genotypic and phenotypic results may exist in recent seroconverters, our data suggest that the role of transmitted NRTI- and PI-resistant variants remain to be fully elucidated in vivo.


Sujet(s)
Agents antiVIH/pharmacologie , Infections à VIH/virologie , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/effets des médicaments et des substances chimiques , Mutation , Inhibiteurs de la transcriptase inverse/pharmacologie , Agents antiVIH/usage thérapeutique , Résistance microbienne aux médicaments/génétique , Association de médicaments , Produits du gène pol/génétique , Génotype , Infections à VIH/traitement médicamenteux , Infections à VIH/immunologie , Protéase du VIH/génétique , Transcriptase inverse du VIH/génétique , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/génétique , Humains , Indinavir/pharmacologie , Indinavir/usage thérapeutique , Phénotype , ARN viral/sang , Études rétrospectives , Inhibiteurs de la transcriptase inverse/usage thérapeutique , Ritonavir/pharmacologie , Ritonavir/usage thérapeutique , Résultat thérapeutique , Zidovudine/pharmacologie , Zidovudine/usage thérapeutique
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE